Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACTEMRA vs ADAGRASIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACTEMRA vs ADAGRASIB: Safety Overview

Metric ACTEMRA ADAGRASIB
Total FAERS Reports 603 899
Deaths Reported 47 315
Death Rate 7.8% 35.0%
Hospitalizations 248 350
Average Patient Age 56.0 yrs 68.3 yrs
% Female Patients N/A 56.4%
FDA Approval Date N/A Dec 12, 2022
Manufacturer N/A Mirati Therapeutics, Inc
Route N/A ORAL
Marketing Status N/A Prescription